New York City has long been known for its thriving black market for drugs, but in the past few years, drug dealers have begun to move their operations to the streets, leaving New Jersey’s drug scene in shambles.
New Jersey lawmakers have made it clear they are taking steps to help, but they may have just made it harder for users to get their hands on these dangerous drugs.
In the past two years, the state has shut down more than 30 underground drug houses, shutting down drug dealers who had previously been able to trade through third parties.
The shutdowns came after several drug dealers were caught smuggling drugs into the state and prosecutors charged them with conspiracy.
But that crackdown has been short-lived, and the state is working on other plans to shut down drug markets.
According to Dr. John Stapleton, the director of the Addiction Research and Treatment Center at Rutgers University School of Medicine, the shutdowns have created a new and dangerous market for New Jersey drug dealers.
“These dealers are more easily tracked, because they’re not selling as much, and because there’s a shortage of the drugs,” he told The Associated Press.
Stapleton said there are a number of factors at play.
“In New Jersey, the market is so fragmented and so fragmented that people who might otherwise sell are not able to do so,” he said.
“It’s very easy for these dealers to move to the dark web, to the Tor network, and they’re able to sell a lot more drugs than they normally would.”
It’s a growing problem in New JerseyThe state has been dealing with a growing demand for drugs as of late.
In 2015, there were roughly 7,500 illegal street drugs sold in New York, according a study by the Drug Policy Alliance.
That number jumped to 11,800 in 2016 and 12,300 in 2017, according the DEA.
New Jersey’s opioid crisis has been particularly devastating.
In March 2017, the U.S. Surgeon General said there were about 6.4 million people in treatment for opioid addiction in the state.
That same year, a federal report found that nearly 2.6 million people have died from opioids, with 1.8 million of those deaths occurring in New Brunswick.
New Brunswick was one of the first states to enact a new law that requires that any new medical marijuana patients be referred to a registered caregiver.
But the law was blocked by a judge, and several local officials have been in court since.
The state’s opioid epidemic has had a profound impact on New Jersey.
While the drug crisis has had significant repercussions for many people, especially those who have been struggling with opioid addiction, New Jersey residents are also dealing with the effects of a lack of affordable, safe, and effective treatment options.
According the U-M’s Dr. Michael Mennen, the opioid crisis is “not going away.”
Mennen is the director and clinical director of a treatment center at the University of New Hampshire.
In the last four years, Mennan has worked with thousands of patients who have sought treatment at his facility.
“When people have access to treatment they’re happier, they’re healthier, they have better relationships with their families, and then they also are able to make choices that may make them less likely to commit crimes,” he explained.
“So that’s a very important factor that we’re trying to address.”
New Jersey lawmakers recently passed a law that makes it easier for opioid users to obtain treatment.
Under the law, if a patient is unable to access a supervised drug treatment facility due to a lack.
of money, they can apply to the Department of Health and Human Services for a waiver and have it processed as an outpatient.
Under the new law, the only way for an opioid user to obtain a drug treatment program is through a licensed health care provider, according Health Commissioner Richard C. Russo.
The law only applies to patients who meet certain criteria, and patients who seek a waiver must pay a $10,000 annual fee.
A small percentage of people are eligible to apply for the waiver, and in recent months, a number have made the application, according Russo.
But most patients who apply do not qualify for the program.
New York City’s opioid addiction crisis has also created a real threat to New Jersey citizens.
In 2016, more than 7,200 people died from drug overdoses, according The New York Times.
The majority of those fatalities occurred in New Haven, Connecticut, and Brooklyn, New York.
While New Jersey has had success with the opioid program, it has not been without its share of problems.
According a 2017 report by the Substance Abuse and Mental Health Services Administration, New Jerseys drug problem is among the highest in the nation.
In that year, 836 people died due to drug overdoses in New Jersey, according TOHS.
The most common type of drug-related overdose death in Newjersey was